fbpx

Tag Archives | CBD

Dr. Jonathan Rothbard, CEO, Chief Scientific Officer and co-founder of Katexco Pharmaceuticals

Dr. Jonathan Rothbard, CEO, Chief Scientific Officer and co-founder of Katexco Pharmaceuticals, a medical cannabis biopharma company based in Palo Alto, California, is this week’s guest on The Green Rush. In addition to his work in the cannabis space, Dr. Rothbard works in the neurology department at Stanford University where he’s also worked in the departments of chemistry and rheumatology. Dr. Rothbard is also the founder of Amylin, which was eventually sold to Bristol-Myers Squibb.

Dr. Rothbard is spearheading the second generation of medical cannabis, where cannabinoids like CBD and THC will be synthesized in labs instead of extracted from plants grown on farms. His mission is to put CBD through clinical trials to prove scientifically that it can be an effective medical treatment in conjunction with other compounds and to patent those compounds and submit them to the FDA for approval as pharmaceuticals.

In addition to our regular hosts Lewis and Anne, we also has a special guest, KCSA colleague Caitlin Kasunich, join us for this week’s conversation.

For listeners interested in the growth of medicinal cannabis, science and the developing relationship between the traditional pharma space and cannabis, this interview is for you! So don’t sit back, lean forward and enjoy!  

Dr. Jonathan Rothbard, CEO, Chief Scientific Officer and co-founder of Katexco Pharmaceuticals

Dr. Jonathan Rothbard, PhD received his BA from Hamilton College (1973) and his PhD from Columbia with Ronald Breslow (1977). His post-doctoral fellowship was with Gerald Edelman at The Rockefeller University after which he was with Gary Schoolnik at Stanford University Medical School where he published the first of 26 manuscripts with Lawrence Steinman in 1986. Subsequently, he was head of the Molecular Immunology Laboratory at the Imperial Cancer Research Fund in London where he first collaborated with Prof. Sir Marc Feldman (1990). He left academia to help establish ImmuLogic in Palo Alto, and founding Amylin in San Diego. Amylin, which he founded in 1987, was a pharmaceuticals company engaged in the discovery, development and commercialization of drugs relating to diseases including obesity and diabetes. The success of Amylin led to another appointment at Stanford for Dr. Rothbard, followed by the founding of CellGate. Leaving CellGate, he returned to an appointment at Stanford, first in the department of chemistry, then rheumatology, and currently in neurology. Amylin was sold to Bristol-Myers Squibb in 2012 for $5.4 Billion USD.  

Links to guest’s social media:

Links and Mentions:

Show Credits:

This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications with special guest Caitlin Kasunich.

Special thanks to our Producer Nick Opich and Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Jane West – Co-Founder and CEO of Cannabis Lifestyle Brand Jane West

Jane West, Co-Founder and CEO of the cannabis lifestyle brand Jane West and one of the most influential women in the industry, is this week’s guest on The Green Rush. Following her entry into the space in 2014 following legalization in Colorado, Jane quickly went on to help found the cannabis networking organization Women Grow, and in 2016, Inc. magazine named her “the most widely recognized female personality in cannabis.” In an industry dominated by major players vying for space in an increasingly crowded marketplace, Jane is unique in that she’s built a well-recognized brand and social following around her name, likeness, and her style.

With Lewis and Anne together again back behind the microphone, they chat with Jane about her well-documented transition into the cannabis space, the challenges she faced as an entrepreneur, the time one of her events was raided by a SWAT team, how the US markets differ from the growing European markets and her disappointment in the lack of small business success in cannabis.

Enjoy!   

Jane West – Co-Founder and CEO of Cannabis Lifestyle Brand Jane West

Jane West is the CEO of the cannabis lifestyle brand Jane West. At Jane West, she develops cannabis accessories and home goods that  invite women to experience the benefits of cannabis and take part in the legal lifestyle. West is also the founder of Women Grow, the cannabis industry’s  largest professional networking organization. Since the launch of her consumption-friendly cannabis events company Edible Events in 2014, she has emerged as a prominent figure in mainstream cannabis culture. An experienced executive with a broad management background, West is  committed to changing the face of women in cannabis, both as consumers and as leaders. West is a leading influencer in the cannabis industry, shifting mainstream perceptions by providing insider access to the modern legal lifestyle. She first became a marijuana media darling early in 2014 with her breakthrough “On a High Note” collaboration between the Colorado  Symphony Orchestra and her other business, Edible Events Company, Colorado’s premiere cannabis event production company. Before joining the cannabis industry, West was a working mother rising through the management ranks as a corporate event planner. After her employer spotted her vaping on CNBC, she was quickly fired. Immediately, West embraced the opportunity to dive headfirst into the cannabis industry as an outspoken advocate for cannabis legalization. In the two years since Colorado legalized cannabis, West has become a fixture of mainstream cannabis  coverage on CNBC, NBC Nightly News, and in the New York Times, Newsweek, Forbes, TIME, the Guardian, and many others

Links to guest’s social media:

Links and Mentions:

Show Credits:

This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications.

Special thanks to our Producer Nick Opich and Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Kashif Shan, CEO and Founder of Folium Biosciences

Kashif Shan, CEO and founder of Folium Biosciences, the largest vertically integrated producer, manufacturer and distributor of hemp-derived phytocannabinoinds, is this week’s guest on the Green Rush!

With the passage of the Farm Bill in 2018, hemp and CBD is now 100% legal so Anne and Lewis sat down with Kashif to get an overview of the current state of the CBD space, the future growth market for hemp derived CBD and when we may see big box retailers take a bigger step into the CBD marketplace. In addition to touching on the overall industry, Kashif provides our listeners an in-depth look at the inception and growth of Folium Biosciences, how the company plans to use the funds it received from a recent investment by Australis Capital, what Folium’s R&D department is working on right now and the story of how Kashif let his conservative parents know he was working in the cannabis industry.

This week’s conversation is sure to be a treat for those who are interested in learning more about the CBD space. So sit back and enjoy!

Kashif Shan is the Founder and CEO of Folium Biosciences. Kashif has spent over 20 years as a High Technology Executive across a range of fields where he oversaw Finance, Facilities, and HR. Kashif founded Folium Biosciences in 2014 and has helped grow the company to become the global leader in non-psychoactive cannabinoids and employs over 250 people. Prior to entering the cannabis space, Kashif was the Founder of Equus Capital, a real estate investment company.

Links to guest’s social media:

Links and Mentions:

Show Credits:

This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Producer Nick Opich and Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter / Instagram: @KCSA_Cannabis

LinkedIn: https://www.linkedin.com/company/green-rush-comms/

Facebook:https://www.facebook.com/KCSACannabiz/

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

 

Powered by WordPress. Designed by WooThemes